These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20017652)

  • 1. Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C.
    Hackl NJ; Bersch C; Feick P; Antoni C; Franke A; Singer MV; Nakchbandi IA
    Scand J Gastroenterol; 2010 Mar; 45(3):349-56. PubMed ID: 20017652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
    Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
    Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
    Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
    Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].
    González Guilabert MI; Hinojosa Mena-Bernal C; del Pozo González J; del Pozo Pérez MA
    Gastroenterol Hepatol; 2010; 33(6):425-32. PubMed ID: 20471720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FibroScore for the non-invasive assessment of liver fibrosis in chronic viral hepatitis.
    Ashraf S; Ahmed SA; Ahmed J; Ali N
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):84-90. PubMed ID: 22313643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered pattern of circulating matrix metalloproteinases -2,- 9 and tissue inhibitor of metalloproteinase-2 in patients with HCV-related chronic hepatitis. Relationship to histological features.
    Bruno CM; Valenti M; Bertino G; Ardiri A; Consolo M; Mazzarino CM; Amoroso A; Neri S
    Panminerva Med; 2009 Dec; 51(4):191-6. PubMed ID: 20195229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of serum IgG, IgA and IgM levels as indicators of hepatic fibrosis in patients with chronic hepatitis C infection].
    Ortarık Z; Toyran A; Sen S; Mart Kömürcü SZ; Güvener E
    Mikrobiyol Bul; 2011 Apr; 45(2):296-305. PubMed ID: 21644073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemical identification and detection of serum fibronectin in liver fibrosis patients with chronic hepatitis C.
    Attallah AM; Zahran F; Ismail H; Omran MM; El-Dosoky I; Shiha GE
    J Immunoassay Immunochem; 2007; 28(4):331-42. PubMed ID: 17885887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum hyaluronic acid and laminin as biomarkers in liver fibrosis.
    Parsian H; Rahimipour A; Nouri M; Somi MH; Qujeq D; Fard MK; Agcheli K
    J Gastrointestin Liver Dis; 2010 Jun; 19(2):169-74. PubMed ID: 20593050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
    D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
    Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of biochemical markers for the prediction of liver fibrosis and necroinflammatory activity in hemodialysis patients with chronic hepatitis C.
    Canbakan M; Senturk H; Canbakan B; Toptas T; Tabak O; Ozaras R; Tabak F; Balcı H; Sut N; Ozbay G
    Nephron Clin Pract; 2011; 117(3):c289-95. PubMed ID: 20847572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.
    Zarski JP; Sturm N; Guechot J; Paris A; Zafrani ES; Asselah T; Boisson RC; Bosson JL; Guyader D; Renversez JC; Bronowicki JP; Gelineau MC; Tran A; Trocme C; De Ledinghen V; Lasnier E; Poujol-Robert A; Ziegler F; Bourliere M; Voitot H; Larrey D; Rosenthal-Allieri MA; Fouchard Hubert I; Bailly F; Vaubourdolle M;
    J Hepatol; 2012 Jan; 56(1):55-62. PubMed ID: 21781944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement activation correlates with liver necrosis and fibrosis in chronic hepatitis C.
    Vasel M; Rutz R; Bersch C; Feick P; Singer MV; Kirschfink M; Nakchbandi IA
    Clin Immunol; 2014 Feb; 150(2):149-56. PubMed ID: 24412908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.